{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:50Z","timestamp":1772119790632,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2002193"],"award-info":[{"award-number":["GNT2002193"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2025894"],"award-info":[{"award-number":["2025894"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016909"],"award-info":[{"award-number":["2016909"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11096-025-01915-1","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T09:00:21Z","timestamp":1745398821000},"page":"1520-1525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A cross-sectional study of prescribing of antiseizure medication for the treatment of pain in Australia"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5033-6248","authenticated-orcid":false,"given":"Ting","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0348-9441","authenticated-orcid":false,"given":"Jenni","family":"Ilomaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3209","authenticated-orcid":false,"given":"Louisa","family":"Picco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"2","key":"1915_CR1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1212\/CON.0000000000001104","volume":"28","author":"BW Abou-Khalil","year":"2022","unstructured":"Abou-Khalil BW. Update on antiseizure medications 2022. CONTINUUM Lifelong Learn Neurol. 2022;28(2):500\u201335.","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"issue":"6","key":"1915_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3821\/145.6.cpj280","volume":"145","author":"C Fukada","year":"2012","unstructured":"Fukada C, Kohler JC, Boon H, et al. Prescribing gabapentin off label: perspectives from psychiatry, pain and neurology specialists. Can Pharm J (Ott). 2012;145(6):280-2841e1.","journal-title":"Can Pharm J (Ott)"},{"key":"1915_CR3","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101120","author":"AL Schaffer","year":"2021","unstructured":"Schaffer AL, Busingye D, Chidwick K, et al. Pregabalin prescribing patterns in Australian general practice, 2012\u20132018: a cross-sectional study. BJGP Open. 2021. https:\/\/doi.org\/10.3399\/bjgpopen20X101120.","journal-title":"BJGP Open"},{"issue":"1","key":"1915_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40122-019-00146-3","volume":"9","author":"AD Kaye","year":"2020","unstructured":"Kaye AD, Granier AL, Garcia AJ, et al. Non-opioid perioperative pain strategies for the clinician: a narrative review. Pain Ther. 2020;9(1):25\u201339.","journal-title":"Pain Ther"},{"issue":"4","key":"1915_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.18773\/austprescr.2023.025","volume":"46","author":"A Athavale","year":"2023","unstructured":"Athavale A, Murnion B. Gabapentinoids: a therapeutic review. Aust Prescr. 2023;46(4):80\u20135.","journal-title":"Aust Prescr"},{"key":"1915_CR6","unstructured":"Department of Health and Aged Care. The Pharmaceutical Benefits Scheme. 2024 (cited 15-08-2024); Available from: https:\/\/www.pbs.gov.au\/medicine\/item\/1834M-4592Q."},{"key":"1915_CR7","first-page":"100302","volume":"13","author":"A Olopoenia","year":"2022","unstructured":"Olopoenia A, Camelo-Castillo W, Qato DM, et al. Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: a nested case-control study. Lancet Reg Health Am. 2022;13:100302.","journal-title":"Lancet Reg Health Am"},{"issue":"2","key":"1915_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/sc.2013.146","volume":"52","author":"S Guy","year":"2014","unstructured":"Guy S, Mehta S, Leff L, et al. Anticonvulsant medication use for the management of pain following spinal cord injury: systematic review and effectiveness analysis. Spinal Cord. 2014;52(2):89\u201396.","journal-title":"Spinal Cord"},{"issue":"12","key":"1915_CR9","first-page":"CD006044","volume":"2013","author":"PJ Wiffen","year":"2013","unstructured":"Wiffen PJ, Derry S, Moore RA. Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2013;2013(12):CD006044.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"1915_CR10","first-page":"CD009183","volume":"2011","author":"D Gill","year":"2011","unstructured":"Gill D, Derry S, Wiffen PJ, et al. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;2011(10):CD009183.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1915_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067746","volume":"13","author":"S Nielsen","year":"2023","unstructured":"Nielsen S, Buchbinder R, Pearce C, et al. Cohort profile: using primary care data to understand opioid prescribing, policy impacts and clinical outcomes (OPPICO) in Victoria, Australia. BMJ Open. 2023;13(5): e067746.","journal-title":"BMJ Open"},{"key":"1915_CR12","unstructured":"BioPortal. SNOMED CT. 2024 [cited 2024 10 July]; Available from: https:\/\/bioportal.bioontology.org\/ontologies\/SNOMEDCT."},{"issue":"12","key":"1915_CR13","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E Von Elm","year":"2014","unstructured":"Von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495\u20139.","journal-title":"Int J Surg"},{"key":"1915_CR14","doi-asserted-by":"publisher","first-page":"100579","DOI":"10.1016\/j.lanepe.2022.100579","volume":"27","author":"J Ashworth","year":"2023","unstructured":"Ashworth J, Bajpai R, Muller S, et al. Trends in gabapentinoid prescribing in UK primary care using the clinical practice research datalink: an observational study. Lancet Reg Health Eur. 2023;27:100579.","journal-title":"Lancet Reg Health Eur"},{"issue":"5","key":"1915_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/HRP.0000000000000227","volume":"27","author":"V Dokkedal-Silva","year":"2019","unstructured":"Dokkedal-Silva V, Berro LF, Galdur\u00f3z JCF, et al. Clonazepam: indications, side effects, and potential for nonmedical use. Harv Rev Psychiatr. 2019;27(5):279\u201389.","journal-title":"Harv Rev Psychiatr"},{"key":"1915_CR16","unstructured":"Pharmaceutical Benefits Advisory Committee, Drug utilisation sub-committee (DUSC) meeting, Pregabalin: 12 Month predicted versus actual analysis 2014."},{"key":"1915_CR17","unstructured":"Pharmaceutical Benefits Advisory Committee. Drug utilisation sub-committee (DUSC) opioid analgesics. 2020; Available from: https:\/\/www.pbs.gov.au\/info\/industry\/listing\/participants\/public-release-docs\/2020-02\/opioid-analgesics."},{"key":"1915_CR18","doi-asserted-by":"publisher","first-page":"117822181880131","DOI":"10.1177\/1178221818801311","volume":"12","author":"AM Peckham","year":"2018","unstructured":"Peckham AM, Evoy KE, Ochs L, et al. Gabapentin for off-label use: evidence-based or cause for concern? Subst Abuse Res Treat. 2018;12:1178221818801311.","journal-title":"Subst Abuse Res Treat"},{"issue":"8","key":"1915_CR19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/jama.2017.21897","volume":"319","author":"JD Wallach","year":"2018","unstructured":"Wallach JD, Ross JS. Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts. JAMA. 2018;319(8):776\u20138.","journal-title":"JAMA"},{"key":"1915_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104053","volume":"117","author":"S Nielsen","year":"2023","unstructured":"Nielsen S, Picco L, Russell G, et al. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: a time series analysis of early outcomes. Int J Drug Policy. 2023;117: 104053.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"1915_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1001\/jamainternmed.2019.0086","volume":"179","author":"CW Goodman","year":"2019","unstructured":"Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern Med. 2019;179(5):695\u2013701.","journal-title":"JAMA Intern Med"},{"issue":"8","key":"1915_CR22","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1111\/bcp.14715","volume":"87","author":"S Nielsen","year":"2021","unstructured":"Nielsen S, Gisev N, Leung J, et al. Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: a five-year prospective cohort study. Br J Clin Pharmacol. 2021;87(8):3092\u2013104.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1915_CR23","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/add.14412","volume":"114","author":"R Cairns","year":"2019","unstructured":"Cairns R, Schaffer AL, Ryan N, et al. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings. Addict. 2019;114(6):1026\u201334.","journal-title":"Addict"},{"key":"1915_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","volume":"81","author":"KE Evoy","year":"2021","unstructured":"Evoy KE, Sadrameli S, Contreras J, et al. Abuse and misuse of pregabalin and gabapentin: a systematic review update. Drugs. 2021;81:125\u201356.","journal-title":"Drugs"},{"issue":"3","key":"1915_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11096-022-01528-y","volume":"45","author":"J Meaadi","year":"2023","unstructured":"Meaadi J, Obara I, Eldabe S, et al. The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials. Int J Clin Pharm. 2023;45(3):556\u201365.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1915_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.717","volume":"9","author":"RJ Li","year":"2021","unstructured":"Li RJ, Caughey GE, Shakib S. Concomitant inpatient prescribing of strong opioids with sedatives: associations with comorbid conditions. Pharmacol Res Perspect. 2021;9(1): e00717.","journal-title":"Pharmacol Res Perspect"},{"issue":"6","key":"1915_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1684\/epd.2019.1105","volume":"6","author":"T Tomson","year":"2019","unstructured":"Tomson T, Battino D, Bromley R, et al. Management of epilepsy in pregnancy: a report from the international league against epilepsy task force on women and pregnancy. Epileptic Disord. 2019;6(6):497\u2013517.","journal-title":"Epileptic Disord"},{"issue":"2","key":"1915_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/1753-6405.12030","volume":"37","author":"SA Hollingworth","year":"2013","unstructured":"Hollingworth SA, Symons M, Khatun M, et al. Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia. Aust N Z J Public Health. 2013;37(2):132\u20138.","journal-title":"Aust N Z J Public Health"},{"issue":"1","key":"1915_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5334\/egems.274","volume":"7","author":"P-ID Lin","year":"2019","unstructured":"Lin P-ID, Daley MF, Boone-Heinonen J, et al. Comparing prescribing and dispensing data of the PCORnet common data model within PCORnet antibiotics and childhood growth study. EGEMs. 2019;7(1):11.","journal-title":"EGEMs"},{"key":"1915_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2020.104189","volume":"141","author":"C Imai","year":"2020","unstructured":"Imai C, Hardie R-A, Franco GS, et al. Harnessing the potential of electronic general practice pathology data in Australia: an examination of the quality use of pathology for type 2 diabetes patients. Int J Med Inform. 2020;141: 104189.","journal-title":"Int J Med Inform"},{"key":"1915_CR31","unstructured":"RACGP, General Practice Health of the Nation 2023. The Royal Australian College of General Practitioners East Melbourne, VIC; 2023. [cited 2024 10 July]; Available from: https:\/\/www.racgp.org.au\/getmedia\/122d4119-a779-41c0-bc67-a8914be52561\/Health-of-the-Nation-2023.pdf"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01915-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-01915-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01915-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T08:31:17Z","timestamp":1757665877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-01915-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1915"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-01915-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5192451\/v1","asserted-by":"object"}]},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}